ME01232B - Etode za dobivanje heksahidrofuro[2,3-b]furan-3-ola - Google Patents
Etode za dobivanje heksahidrofuro[2,3-b]furan-3-olaInfo
- Publication number
- ME01232B ME01232B MEP-2011-65A MEP6511A ME01232B ME 01232 B ME01232 B ME 01232B ME P6511 A MEP6511 A ME P6511A ME 01232 B ME01232 B ME 01232B
- Authority
- ME
- Montenegro
- Prior art keywords
- hexahydrofuro
- furan
- methods
- preparation
- enantiomer
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/20—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Furan Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06123752 | 2006-11-09 | ||
EP07822416A EP2089371B1 (en) | 2006-11-09 | 2007-11-09 | Methods for the preparation of hexahydrofuro[2,3-b]furan-3-ol |
PCT/EP2007/062119 WO2008055970A2 (en) | 2006-11-09 | 2007-11-09 | Methods for the preparation of hexahydrofuro[2,3-b]furan-3-ol |
Publications (1)
Publication Number | Publication Date |
---|---|
ME01232B true ME01232B (me) | 2013-06-20 |
Family
ID=37692659
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MEP-2011-65A ME01232B (me) | 2006-11-09 | 2007-11-09 | Etode za dobivanje heksahidrofuro[2,3-b]furan-3-ola |
Country Status (22)
Country | Link |
---|---|
US (1) | US8153829B2 (me) |
EP (1) | EP2089371B1 (me) |
JP (1) | JP5491862B2 (me) |
CN (2) | CN101541775B (me) |
AT (1) | ATE497499T1 (me) |
AU (1) | AU2007316562B2 (me) |
BR (1) | BRPI0718706B8 (me) |
CA (1) | CA2669014C (me) |
CY (1) | CY1111407T1 (me) |
DE (1) | DE602007012365D1 (me) |
DK (1) | DK2089371T3 (me) |
ES (1) | ES2359949T3 (me) |
HR (1) | HRP20110258T1 (me) |
IL (1) | IL198270A (me) |
ME (1) | ME01232B (me) |
MX (1) | MX2009004957A (me) |
PL (1) | PL2089371T3 (me) |
PT (1) | PT2089371E (me) |
RS (1) | RS51675B (me) |
RU (1) | RU2464266C2 (me) |
SI (1) | SI2089371T1 (me) |
WO (1) | WO2008055970A2 (me) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010075887A1 (en) * | 2008-12-30 | 2010-07-08 | Oxyrane (Uk) Limited | Methods and intermediates useful in the synthesis of hexahydrofuro[2,3-b]furan-3-ol |
US8921415B2 (en) | 2009-01-29 | 2014-12-30 | Mapi Pharma Ltd. | Polymorphs of darunavir |
US9062065B2 (en) | 2009-10-30 | 2015-06-23 | Lupin Limited | Process for preparation of darunavir and darunavir ethanolate of fine particle size |
CN102686594A (zh) | 2009-12-16 | 2012-09-19 | 熙德隆研究基金会 | 地瑞那韦的多晶型物 |
ES2516916T3 (es) | 2010-01-28 | 2014-10-31 | Mapi Pharma Limited | Procedimiento para la preparación de darunavir e intermedios de darunavir |
EP2571355B1 (en) | 2010-05-20 | 2016-09-07 | Hetero Research Foundation | Crystalline hydrochloride salt of darunavir |
CN102617586B (zh) * | 2011-01-26 | 2016-04-06 | 浙江九洲药业股份有限公司 | 地瑞那韦中间体的制备方法 |
EP2887807B1 (en) * | 2012-08-22 | 2019-09-18 | Merck Sharp & Dohme Corp. | Benzimidazole hexahydrofuro[3,2-b]furan derivatives useful as amp-activated protein kinase activators |
CN103864813B (zh) * | 2012-12-18 | 2017-02-22 | 上海迪赛诺化学制药有限公司 | 一种合成六氢呋喃并[2,3‑b]呋喃‑3‑醇及其对映体的方法 |
CN103896886A (zh) * | 2012-12-31 | 2014-07-02 | 上海迪赛诺化学制药有限公司 | 一种达鲁那韦中间体及其制备方法和应用 |
TW201514188A (zh) * | 2013-03-13 | 2015-04-16 | Lantheus Medical Imaging Inc | 製備釓磷維塞三鈉單水合物之方法 |
CN103664976B (zh) * | 2013-12-12 | 2015-11-04 | 惠州市莱佛士制药技术有限公司 | 一种顺式六氢呋喃并[2,3-b]呋喃-3-醇的制备方法 |
CN113307783B (zh) * | 2016-05-07 | 2023-04-07 | 成都博腾药业有限公司 | 一种制备地瑞那韦中间体的方法 |
CN112300186B (zh) * | 2019-08-01 | 2024-04-30 | 浙江九洲药业股份有限公司 | 六氢呋喃并呋喃醇衍生物的制备方法、其中间体及其制备方法 |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69415326T2 (de) | 1993-08-24 | 1999-06-02 | G.D. Searle & Co., Chicago, Ill. | Hydroxyaminosulfonamide verwendbar als inhibitoren retroviraler proteasen |
DE69512220T2 (de) | 1994-03-07 | 2000-03-16 | Vertex Pharmaceuticals Inc. | Sulfonamidderivate als aspartylprotease-inhibitoren |
JP3665343B2 (ja) | 1995-02-03 | 2005-06-29 | 株式会社カネカ | α−ハロケトン、α−ハロヒドリン及びエポキシドの製造法 |
WO1997018205A1 (en) | 1995-11-15 | 1997-05-22 | G.D. Searle & Co. | Substituted sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors |
US5990313A (en) * | 1996-10-21 | 1999-11-23 | Eastman Chemical Company | Preparation of 3-alkyltetrahydrofurans |
EP0932607A2 (en) * | 1996-10-21 | 1999-08-04 | Eastman Chemical Company | Preparation of 3-alkyltetrahydrofurans |
US5856531A (en) * | 1996-10-21 | 1999-01-05 | Eastman Chemical Company | Preparation of 3-methytetra-hydrofuran from 2,3-dihydrofuran |
DK1086076T3 (da) | 1998-06-19 | 2005-03-29 | Vertex Pharma | Sulfonamidinhibitorer af aspartylprotease |
WO1999067417A2 (en) | 1998-06-23 | 1999-12-29 | The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Fitness assay and associated methods |
WO1999067254A2 (en) | 1998-06-23 | 1999-12-29 | The United States Of America Represented By The Secretary, Department Of Health And Human Services | Multi-drug resistant retroviral protease inhibitors and use thereof |
US6278002B1 (en) | 1998-08-25 | 2001-08-21 | Kaneka Corporation | Process for the preparation of (2r,3s)-3-amino-1,2-oxirane |
ATE334121T1 (de) | 1999-01-29 | 2006-08-15 | Kaneka Corp | Verfahren zur herstellung von threo-1,2-epoxy-3- amino-4-phenylbutan-derivaten |
DK1159278T3 (da) | 1999-02-12 | 2006-04-10 | Vertex Pharma | Inhibitorer af aspartylprotease |
AR031520A1 (es) | 1999-06-11 | 2003-09-24 | Vertex Pharma | Un compuesto inhibidor de aspartilo proteasa, una composicion que lo comprende y un metodo para tratar un paciente con dicha composicion |
KR100708221B1 (ko) | 1999-08-31 | 2007-04-17 | 아지노모토 가부시키가이샤 | 에폭사이드 결정의 제조방법 |
OA12053A (en) | 1999-10-06 | 2006-05-02 | Tibotec Pharm Ltd | HexahydrofuroÄ2,3-bÜfuran-3-yl-N-ä3-Ä(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)aminoÜ-1-benzyl-2-hydroxypropylücarbamate as retroviral protease inhibitor. |
WO2002060905A2 (en) | 2000-10-24 | 2002-08-08 | Glaxo Group Ltd | METHOD FOR PREPARING HIV PROTEASE INHIBITOR INTERMEDIATES |
US6764545B2 (en) | 2000-12-12 | 2004-07-20 | Ajinomoto Co., Inc. | Production method of epoxide crystal |
DE60234952D1 (de) * | 2001-09-10 | 2010-02-11 | Tibotec Pharm Ltd | VERFAHREN ZUR HERSTELLUNG VON HEXAHYDROFUROc2,3-BÜFURAN-3-OL |
DE60213874T2 (de) | 2001-09-20 | 2007-10-18 | Smithkline Beecham Corp. | Verfahren zur herstellung von protease hemmenden zwischenprodukten |
DK2767539T3 (en) * | 2002-05-16 | 2017-09-11 | Janssen Sciences Ireland Uc | Pseudopolymorphic forms of an HIV protease inhibitor |
US20050261507A1 (en) * | 2002-06-27 | 2005-11-24 | Doan Brian D | Preparation of stereoisomers of (3alpha/beta, 6alpha/beta)hexahydrofuro[2,3-b]furan-3-ol |
WO2004033462A2 (en) | 2002-10-09 | 2004-04-22 | The Board Of Trustees Of The University Of Illinois | METHOD OF PREPARING (3R, 3aS, 6aR) -3- HYDROXYHEXAHYDROFURO [2, 3-b] FURAN AND RELATED COMPOUNDS |
WO2004060895A1 (ja) | 2002-12-27 | 2004-07-22 | Sumitomo Chemical Company, Limited | ヘキサヒドロフロフラノール誘導体の製造方法、その中間体及びその製造方法 |
PL1725566T3 (pl) * | 2003-12-23 | 2009-11-30 | Janssen Sciences Ireland Uc | Sposób wytwarzania (1s,2r)-3-[[(4-aminofenylo)sulfonylo](izobutylo)amino]-1-benzylo-2-hydroksypropylokarbaminianu (3r,3as,6ar)-heksahydrofuro-[2,3-b]furan-3-ylu |
TWI383975B (zh) | 2004-03-31 | 2013-02-01 | Tibotec Pharm Ltd | 製備(3R,3aS,6aR)六氫-呋喃并〔2,3-b〕呋喃-3-醇之方法 |
-
2007
- 2007-11-09 SI SI200730567T patent/SI2089371T1/sl unknown
- 2007-11-09 MX MX2009004957A patent/MX2009004957A/es active IP Right Grant
- 2007-11-09 PL PL07822416T patent/PL2089371T3/pl unknown
- 2007-11-09 BR BRPI0718706A patent/BRPI0718706B8/pt active IP Right Grant
- 2007-11-09 US US12/447,537 patent/US8153829B2/en active Active
- 2007-11-09 CN CN2007800418345A patent/CN101541775B/zh active Active
- 2007-11-09 JP JP2009535738A patent/JP5491862B2/ja active Active
- 2007-11-09 RU RU2009121792/04A patent/RU2464266C2/ru active
- 2007-11-09 PT PT07822416T patent/PT2089371E/pt unknown
- 2007-11-09 WO PCT/EP2007/062119 patent/WO2008055970A2/en active Application Filing
- 2007-11-09 DK DK07822416.9T patent/DK2089371T3/da active
- 2007-11-09 AT AT07822416T patent/ATE497499T1/de active
- 2007-11-09 AU AU2007316562A patent/AU2007316562B2/en active Active
- 2007-11-09 ME MEP-2011-65A patent/ME01232B/me unknown
- 2007-11-09 EP EP07822416A patent/EP2089371B1/en active Active
- 2007-11-09 ES ES07822416T patent/ES2359949T3/es active Active
- 2007-11-09 RS RS20110169A patent/RS51675B/en unknown
- 2007-11-09 CA CA2669014A patent/CA2669014C/en active Active
- 2007-11-09 CN CN201110342987.1A patent/CN102432621B/zh active Active
- 2007-11-09 DE DE602007012365T patent/DE602007012365D1/de active Active
-
2009
- 2009-04-21 IL IL198270A patent/IL198270A/en active IP Right Grant
-
2011
- 2011-04-11 HR HR20110258T patent/HRP20110258T1/hr unknown
- 2011-05-02 CY CY20111100423T patent/CY1111407T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL198270A0 (en) | Methods for the preparation of hexahydrofuro[2,3-b]furan-3-ol | |
ZA200609008B (en) | Methods for the preparation of (3R, 3aS, 6aR) hexahydrofuro[2,3-b]furan-3-ol | |
IL194122A (en) | Process for making (6ar, 3as, 3r) hexahydroporo [3,2– b] furan – 3 – val | |
IL211191A (en) | Oxalate salt of (3as, 4r, 6s, 6ar) –6– (2– hydroxyethoxy) –2,2 – dimethyl tetrahydro –3 ah– cyclopenta [d] [1,3] dioxol – 4 – amine | |
IL220913A (en) | Puro [2,3– b] pyran derivatives are useful in the synthesis of compounds similar to halochondrine b | |
ZA201202025B (en) | INTERMEDIATES USEFUL IN THE PREPARATION OF PYRROLO[2,3-b] PYRIDINE DERIVATIVES | |
WO2010077740A3 (en) | Novel antiviral compounds, compositions, and methods of use | |
SG148192A1 (en) | Azabenzimidazole derivatives, their manufacture and use as anti-cancer agents | |
ZA201004823B (en) | Novel pyrazolo [3,4-d]pyrimidine derivatives as anti-cancer agents | |
MX2010007404A (es) | Procedimiento para la preparacion de asenapina y productos intermediarios utilizados en dicho procedimiento. | |
WO2008017074A3 (en) | Dyes and precursors and conjugates thereof | |
WO2007076116A3 (en) | Intermediates for preparing solifenacin | |
WO2006122769A3 (de) | Substituierte spiro-verbindungen und deren verwendung zur herstellung von arzneimitteln gegen schmerz | |
EP2468751A3 (en) | Processes for the preparation of 5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenzo[2,3:6,7]oxepino[4,5-c]pyrrole | |
SMT201500309B (it) | Procedimento per la preparazione di benzil [(3as,4r,6s,6ar)-6-idrossi-2,2-dimetiltetraidro-3ahciclopenta[d][1,3]diossol]-4-il]carbammato ed intermedi nel procedimento | |
LT2643326T (lt) | (3r,3as,6ar)-heksahidrofuro[2,3-b]furan-3-olio gavimo būdas | |
WO2010151476A3 (en) | Crystalline forms of (3r, 3as, 6ar) - hexahydrofuro [2,3-b] furan-3-yl (1s,2r) - (1-{4-[ (diethoxyphosphoryl) methoxy] pheny1}-3-hydroxy-4- [4-methoxy-n- (2-methylpropyl) benzenesul - fonamido] butan-2-yl) carbamate | |
UA54671U (en) | use of 4,3'-spiro[(2-amino-3-cyano-4,5-dihydropirane[3,2-c]chromen-5-on)-5-methyl-2'-oxyndol] as an anxyolytic | |
HU0402692D0 (en) | Procedure for making of translucent space-element, as well as translucent space-element |